Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Q-linea AB ( (SE:QLINEA) ).
Q-linea AB’s nomination committee has proposed the re-election and election of board members, including Johan Bygge as chairman and Sebastian Backlund as a new member, at the upcoming annual general meeting. These appointments are expected to strengthen Q-linea’s strategic direction, leveraging Bygge’s global business experience and Backlund’s financial expertise, as the company continues its commercialization phase.
More about Q-linea AB
Q-linea is a company specializing in rapid antimicrobial susceptibility testing (AST) systems, notably the ASTar® system, which aids hospitals in swiftly optimizing treatments for bloodstream infections and sepsis. Headquartered in Uppsala, Sweden, with regional offices in Italy and the USA, Q-linea aims to enhance healthcare sustainability and safeguard antibiotic efficacy.
Average Trading Volume: 46,346,270
Current Market Cap: SEK195.7M
See more data about QLINEA stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue